Newest first. 5.2k questions across 107 tags.
I would rather spend on verification than on volume. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan…
Concretely: 124 kg · 1,100 kcal. I want the working, not the result — I need to be able to redo it with different numbers. I care about the precision as well as the…
Conditions: 10 mg · 2 mL. I want the working, not the result — I need to be able to redo it with different numbers. I care about the precision as well as the value —…
Concretely: 10 mg · 1 mL · 0.9% sodium chloride · a GLP-1 receptor agonist. I want to decide this in advance so that I am not deciding it under pressure later. Assume…
For reference: VendorInvestigate · PeptideMeter · a GLP-1 receptor agonist. I am trying to choose between two options that are usually discussed as though only one…
Transit was eleven days with two scanning gaps, so the thermal history is partly inferred. I have read the obvious sources and they disagree with each other, so I…
The particulars: tirzepatide · 20 mg. I would like the arithmetic checked rather than the conclusion asserted. I have deliberately not used an online calculator…
The specifics, since they change the answer: triglycerides · ten weeks · a GLP-1 receptor agonist. Something has gone wrong and I would like to know how badly before…
For reference: an 18G drawing needle · ecnoglutide · 20 mg/mL. I am trying to choose between two options that are usually discussed as though only one exists. I am…
I received a mapping report on tirzepatide. It states "sequence coverage: 100%" in bold at the top, and then the fragment table has exactly two entries in it.…
For reference: reflux · five · a GLP-1 receptor agonist. I have read the obvious sources and they disagree with each other, so I would rather ask people who have…
What I am working with: a 27G needle · cagrilintide · 2.5 mg/mL. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I…
What I am working with: orforglipron · 2–8 °C · forty-two days. I am trying to build something sustainable rather than something thorough that I will abandon. I have…
Setup, so nobody has to ask: a 25G drawing needle · mazdutide · 6.67 mg/mL. I suspect the honest answer is that it depends, in which case I would like to know on…
What I am working with: dulaglutide · phosphate-buffered diluent. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody…
Setup, so nobody has to ask: lot-specific certificate · JEEP. I am trying to build something sustainable rather than something thorough that I will abandon. I have…
Stated plainly: dulaglutide · two weeks · 2–8 °C. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I would…
Numbers first: a GLP-1 receptor agonist · six weeks · 4 °C. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would…
I have the full paper rather than the abstract, and the supplementary appendix. I can predict the outcome but I cannot explain it, which means I will get the next…
I am reading the trial table rather than the press release, which is why the numbers differ. I can parse the result. I am less sure what it licenses me to conclude. I…
Details up front: Zhuhai · the United Kingdom. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
Conditions: 96.4% · VendorInvestigate · 98.2%. I have two candidate explanations and no way to distinguish them. The same procedure has worked without incident…
Conditions: 4 °C · tirzepatide. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me at one. Is there data…
Conditions: 97.1% · date of analysis. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result,…